Daan Gene Co., Ltd. (SHE:002030)

China · Delayed Price · Currency is CNY

6.15

+0.12 (1.99%)

At close: Mar 6, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2024	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Jan '24 Jan 1, 2024	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Biological Products and Related Business	821.09M	1.15B	12.01B	-	-
Biological Products and Related Business Growth	-28.53%	-90.43%	-	-	-
Financial Business	32.05M	32.04M	35.90M	-	-
Financial Business Growth	0.00%	-10.73%	-	-	-
Intersegment Elimination	-110.00K	-	-	-	-
Total	853.02M	1.18B	12.05B	-	-
Total Growth	-27.76%	-90.20%	-	-	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2024	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Jan '24 Jan 1, 2024	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
China	853.02M	1.18B	12.05B	7.66B	5.34B
China Growth	-27.76%	-90.20%	57.17%	43.49%	386.35%
Total	853.02M	1.18B	12.05B	7.66B	5.34B
Total Growth	-27.76%	-90.20%	57.17%	43.49%	386.35%

Source: S&P Global Market Intelligence.